Premium
EFFECT OF RESERPINE ON CATECHOLAMINE CONTENTS AND MET‐ENKEPHALIN AND β‐ENDORPHIN LEVELS IN THE HYPOTHALAMUS AND THE PITUITARY
Author(s) -
Tang Fai
Publication year - 1991
Publication title -
clinical and experimental pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.752
H-Index - 103
eISSN - 1440-1681
pISSN - 0305-1870
DOI - 10.1111/j.1440-1681.1991.tb01474.x
Subject(s) - reserpine , medicine , hypothalamus , endocrinology , catecholaminergic , enkephalin , catecholamine , anterior pituitary , pituitary gland , opioid peptide , chemistry , dopaminergic , endorphins , dopamine , opioid , biology , receptor , hormone
SUMMARY 1. The effects of reserpine treatment on the contents of catecholamines and opioid peptides have been studied in the rat hypothalamus and pituitary. 2. Hypothalamic and pituitary catecholamines were drastically depleted following acute reserpine treatment. 3. Reserpine treatment also resulted in a significant decrease in immunoactive met‐enkephalin content in both the hypothalamus (25%) and the anterior lobe (50%), but not in the neurointermediate lobe of the pituitary. 4. No changes were observed in immunoactive β‐endorphin levels. 5. These findings suggest that the met‐enkephalin contents in the hypothalamus and the anterior pituitary may be under catecholaminergic control. 6. The lack of effect of acute reserpine treatment on immunoactive β‐endorphin contents might be due to the opposing effects of adrenergic and dopaminergic mechanisms.